NANOLEK was nominated for the second stage of project selection for the Priority-2.0 National Award, dedicated to the practical application of advanced technologies.

The award organizers identified a new category called Overcoming, which can include innovative products, technological solutions, and new efficient technologies in the battle against the COVID-19 pandemic. NANOLEK passed the expert council’s selection in the nomination with the Efferon hemosorption columns, which have already proven their effectiveness (the columns have been successfully used in medical institutions in many cities of Russia).

Consequently, NANOLEK has been nominated in three categories for the Priority-2.0 Award in 2020:

· Efferon Hemosorption columns (the Pharmaceuticals and Microbiological Industry Nomination);

· Hunterase medicine (the Pharmaceuticals and Microbiological Industry Nomination);

· Efferon Hemosorption columns (the Overcoming Special Nomination).

The jury’s final voting and the selection of the Priority Award winners, as well as the grand award ceremony, will take place in the second half of October 2020 in Moscow.

Participation in the Priority Award has an impact on developing high-tech products and strengthening the position of domestic commodities in Russian and international markets. The award is a socially meaningful event and is widely supported by the leading Russian media.